CARE Hospitals performs India’s first Bioresorbable vascular scaffold implantation

• Saves the life of a 68-year-old with 99% stenosis in one major artery of heart (LAD)

Hyderabad, 03 Feb 2021: A team of cardiologists at CARE Hospital, Hitech City, led by Dr Bharat Vijay Purohit performed India’s first new generation Bioresorbable vascular scaffold (BVS) on a 68-year-old patient. A BVS is a non-metallic mesh tube that is used to treat a narrowed artery, is similar to a stent, but slowly dissolves once the blocked artery can function naturally again and stays open on its own.

The patient, visited CARE Hospitals and was admitted with severe chest discomfort. An angiogram revealed 99% stenosis in one major artery of the heart (LAD). Dr Purohit along with consultant cardiologist Dr. Sujit Tripathy immediately called for a discussion and it was decided that the patient has to be implanted with a Bioresorbable Vascular Scaffold (BVS).

Speaking about the surgery Dr Bharat Vijay Purohit, Director and Head of Department, Cardiology, CARE Hospitals said, “The condition of the patient was severe and we acted quickly with the right treatment. The BVS was implanted and the surgery went without any complications. The scaffold will dissolve in 2-3 years.”

“The technology of Angioplasty and stent has evolved over the last 4 decades from plain balloon angioplasty to bare metal stent to drug eluting stent and more recently the 4th generation Bioresorbable Vascular scaffold. Similar to a small mesh tube, BVS is designed to help open up a blocked artery in the heart and restore blood flow to the heart muscle. BVS gradually dissolves once the artery can stay open on its own, potentially allowing the blood vessel to function naturally again,” he added.

Dr. Ravi Kiran Hospital Chief Operating Officer CARE Hospitals Hitech city, said, “BVS is made of a material commonly used in other medical devices, such as dissolving stitches. This material allows the BVS to break down into elements already found in your body like water (H2O) and carbon dioxide (CO2), enabling the artery to return to a more natural state.”

“The new device will eliminate the concern about receiving a permanent implant, enables the patient to resume everyday activities, positively impact long-term heart health and helps to reduce your chance of future Coronary artery disease symptoms,” he added.
 
Post the surgery, the patient is recovering well and Dr Purohit is in constant touch with him for any requirements. CARE Hospital has always remained at the forefront of embracing newer innovations and giving latest and best treatment to its patient at affordable cost.